{"id":"https://openalex.org/W2097686863","doi":"https://doi.org/10.1586/erp.11.70","title":"The impact of reference-pricing systems in Europe: a literature review and case studies","display_name":"The impact of reference-pricing systems in Europe: a literature review and case studies","publication_year":2011,"publication_date":"2011-11-18","ids":{"openalex":"https://openalex.org/W2097686863","doi":"https://doi.org/10.1586/erp.11.70","mag":"2097686863","pmid":"https://pubmed.ncbi.nlm.nih.gov/22098289"},"language":"en","primary_location":{"id":"doi:10.1586/erp.11.70","doi":"https://doi.org/10.1586/erp.11.70","is_oa":false,"landing_page_url":"https://doi.org/10.1586/erp.11.70","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046601861","display_name":"Pieter Dylst","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Pieter Dylst","raw_affiliation_strings":["Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium. pieter.dylst@pharm.kuleuven.be","Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium. pieter.dylst@pharm.kuleuven.be","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016982472","display_name":"Arnold G. Vulto","orcid":"https://orcid.org/0000-0002-8439-2800","observed_orcids":["https://orcid.org/0000-0002-8439-2800"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Arnold Vulto","raw_affiliation_strings":["Hospital Pharmacy, Erasmus University Medical Center, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands; Hospital Pharmacy, Erasmus University Medical Center, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Pharmacy, Erasmus University Medical Center, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands; Hospital Pharmacy, Erasmus University Medical Center, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047342188","display_name":"Steven Simoens","orcid":"https://orcid.org/0000-0002-9512-2005","observed_orcids":["https://orcid.org/0000-0002-9512-2005"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Steven Simoens","raw_affiliation_strings":["Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium; Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium","KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium; Research Centre for Pharmaceutical Care & Pharmaco-economics, KU Leuven, Belgium, Herestraat 49, O&N 2, PO Box 521, 3000 Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.0464,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.86430678,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"11","issue":"6","first_page":"729","last_page":"737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11531","display_name":"Healthcare Systems and Reforms","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/reference-pricing","display_name":"reference pricing","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmaceutical-expenditure","display_name":"pharmaceutical expenditure","score":0.6840000152587891},{"id":"https://openalex.org/keywords/drug-prices","display_name":"drug prices","score":0.9160000085830688},{"id":"https://openalex.org/keywords/drug-use","display_name":"drug use","score":0.8199999928474426},{"id":"https://openalex.org/keywords/health-outcomes","display_name":"health outcomes","score":0.6669999957084656},{"id":"https://openalex.org/keywords/pharmaceutical-policy","display_name":"pharmaceutical policy","score":0.4099999964237213},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.906000018119812},{"id":"https://openalex.org/keywords/proton-pump-inhibitors","display_name":"proton pump inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/european-healthcare-systems","display_name":"European health systems","score":0.5839999914169312}],"concepts":[{"id":"https://openalex.org/C2908795282","wikidata":"https://www.wikidata.org/wiki/Q7240896","display_name":"Drug pricing","level":2,"score":0.6773470640182495},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.6289613246917725},{"id":"https://openalex.org/C136197465","wikidata":"https://www.wikidata.org/wiki/Q1729295","display_name":"Variety (cybernetics)","level":2,"score":0.5777971148490906},{"id":"https://openalex.org/C2988170871","wikidata":"https://www.wikidata.org/wiki/Q11000047","display_name":"Healthcare system","level":3,"score":0.5376976132392883},{"id":"https://openalex.org/C2910862244","wikidata":"https://www.wikidata.org/wiki/Q7240896","display_name":"Drug prices","level":2,"score":0.5090703368186951},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.4682620167732239},{"id":"https://openalex.org/C2775924081","wikidata":"https://www.wikidata.org/wiki/Q55608371","display_name":"Control (management)","level":2,"score":0.45336678624153137},{"id":"https://openalex.org/C2780193402","wikidata":"https://www.wikidata.org/wiki/Q3394670","display_name":"Pricing strategies","level":2,"score":0.44524848461151123},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.4405127465724945},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.4379812479019165},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.409898579120636},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.36656251549720764},{"id":"https://openalex.org/C134560507","wikidata":"https://www.wikidata.org/wiki/Q753291","display_name":"Environmental economics","level":1,"score":0.33297497034072876},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.18684765696525574},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.17409780621528625},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.16531500220298767},{"id":"https://openalex.org/C187736073","wikidata":"https://www.wikidata.org/wiki/Q2920921","display_name":"Management","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005102","descriptor_name":"Health Expenditures","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D006291","descriptor_name":"Health Policy","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007349","descriptor_name":"Insurance, Health, Reimbursement","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D033161","descriptor_name":"Government Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054328","descriptor_name":"Proton Pump Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D054328","descriptor_name":"Proton Pump Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1586/erp.11.70","doi":"https://doi.org/10.1586/erp.11.70","is_oa":false,"landing_page_url":"https://doi.org/10.1586/erp.11.70","pdf_url":null,"source":{"id":"https://openalex.org/S98544388","display_name":"Expert Review of Pharmacoeconomics & Outcomes Research","issn_l":"1473-7167","issn":["1473-7167","1744-8379"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-c","anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Pharmacoeconomics & Outcomes Research","raw_type":"journal-article"},{"id":"pmid:22098289","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22098289","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of pharmacoeconomics & outcomes research","raw_type":"Journal Article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/a6d7919e-a388-45d0-bdf0-141229ba385a","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/a6d7919e-a388-45d0-bdf0-141229ba385a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Future Drugs, 11(6), 729 - 737. Taylor & Francis Ltd","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/a6d7919e-a388-45d0-bdf0-141229ba385a","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/1765/67080","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Dylst, P, Vulto, A & Simoens, S 2011, 'The impact of reference-pricing systems in Europe: a literature review and case studies', Future Drugs, vol. 11, no. 6, pp. 729-737. https://doi.org/10.1586/erp.11.70","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2521900277","doi":null,"is_oa":false,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/353198","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W909847195","https://openalex.org/W1492815770","https://openalex.org/W1496334374","https://openalex.org/W1526248680","https://openalex.org/W1563907988","https://openalex.org/W1968341607","https://openalex.org/W2015443986","https://openalex.org/W2026284926","https://openalex.org/W2029937526","https://openalex.org/W2037406601","https://openalex.org/W2038594714","https://openalex.org/W2045394072","https://openalex.org/W2047417552","https://openalex.org/W2061706224","https://openalex.org/W2062808155","https://openalex.org/W2063450880","https://openalex.org/W2064342741","https://openalex.org/W2078712977","https://openalex.org/W2095170778","https://openalex.org/W2113317991","https://openalex.org/W2114265987","https://openalex.org/W2117366316","https://openalex.org/W2124116280","https://openalex.org/W2148553478","https://openalex.org/W2315162608","https://openalex.org/W2478461731","https://openalex.org/W2520972379","https://openalex.org/W2576432082","https://openalex.org/W3121789473","https://openalex.org/W3122851064","https://openalex.org/W3124786975","https://openalex.org/W3125476117"],"related_works":["https://openalex.org/W3010973738","https://openalex.org/W2333706965","https://openalex.org/W2168919816","https://openalex.org/W2007675146","https://openalex.org/W2257882402","https://openalex.org/W178376596","https://openalex.org/W2738611934","https://openalex.org/W7218163174","https://openalex.org/W4406858367","https://openalex.org/W4402343212"],"abstract_inverted_index":{"As":[0],"healthcare":[1],"budgets":[2],"are":[3],"continuously":[4],"rising":[5],"in":[6],"Europe,":[7],"governments":[8,25],"implement":[9],"a":[10,21],"wide":[11],"variety":[12],"of":[13,43,77,86,100,112],"policies":[14],"to":[15,26,80],"control":[16],"them.":[17],"Reference":[18,72,91],"pricing":[19,73,92],"is":[20],"popular":[22],"tool":[23],"for":[24,62,66],"contain":[27],"pharmaceutical":[28],"expenditures,":[29],"as":[30],"22":[31],"European":[32],"countries":[33],"have":[34],"implemented":[35],"this":[36],"system.":[37,120],"This":[38],"article":[39],"evaluates":[40],"the":[41,81,84,97,119],"impact":[42],"reference-pricing":[44],"systems":[45],"on":[46],"drug":[47,49,51,101],"use,":[48],"prices,":[50],"expenditure":[52,102],"and":[53,64,83],"health":[54],"outcomes.":[55],"In":[56],"addition,":[57],"two":[58],"case":[59],"studies,":[60],"one":[61,65],"statins":[63],"proton-pump":[67],"inhibitors,":[68],"were":[69,114],"carried":[70],"out.":[71],"drives":[74],"down":[75],"prices":[76],"drugs":[78,88],"subject":[79],"system":[82],"use":[85],"these":[87],"has":[89,103],"increased.":[90],"creates":[93],"short-term":[94],"savings":[95],"but":[96],"long-term":[98],"growth":[99],"not":[104,115],"been":[105],"reduced":[106],"by":[107,118],"reference":[108],"pricing.":[109],"Health":[110],"outcomes":[111],"patients":[113],"negatively":[116],"affected":[117]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}